Related Experiment Videos
Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension
George L Bakris1, Michael A Weber
1Hypertensive Diseases Unit, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
Insights
Most patients with hypertension need multiple medications. Vasodilating beta-blockers like carvedilol offer benefits over other beta-blockers, with once-daily carvedilol potentially being superior for managing high blood pressure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension management often requires multiple antihypertensive medications.
- Beta-blockers are recommended for hypertension, especially with compelling indications.
- Significant differences exist among beta-blockers regarding pharmacology, hemodynamics, and tolerability.
Purpose of the Study:
- To highlight the evidence-based selection of beta-blockers for high-risk hypertension.
- To compare vasodilating beta-blockers with other classes.
- To evaluate the potential benefits of carvedilol CR.
Main Methods:
- Review of pharmacologic properties and clinical trial data of beta-blockers.
- Focus on vasodilating beta-blockers, specifically carvedilol.
- Comparison of carvedilol CR (once daily) versus twice-daily regimens.
Main Results:
- Vasodilating beta-blockers, such as carvedilol, effectively lower blood pressure.
- Carvedilol avoids adverse hemodynamic, renal, and metabolic effects common to other beta-blockers.
- Once-daily carvedilol CR may offer an improved regimen.
Conclusions:
- The choice of beta-blocker for high-risk hypertension should be evidence-based, considering pharmacologic differences.
- Vasodilating beta-blockers represent a favorable option.
- Carvedilol CR presents a potentially preferable dosing strategy.
Abstract:
Few patients with hypertension meet recommended target blood pressure goals, and most hypertensive patients require at least 2 antihypertensive medications from different pharmacologic classes to adequately lower blood pressure. beta-Blockers are guideline-recommended for the treatment of hypertension with compelling indications. beta-Blockers differ with respect to pharmacology (particularly receptor biology and ancillary properties), hemodynamic effects, and tolerability. In clinical practice, the choice of beta-blockers for individual patients with hypertension is often based on practical issues such as convenience and cost. However, given the pharmacologic and clinical trial data demonstrating differences, the choice of beta-blocker for the treatment of high-risk hypertension should be evidence-based. Vasodilating beta-blockers, such as carvedilol, decrease blood pressure without the concerning hemodynamic, renal, and metabolic responses associated with most beta-blockers. The use of carvedilol CR (once daily) may be preferable to a twice-daily regimen.
Related Concept Videos
IV Infusion to Oral Dosing: Conversion Methods
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Oral Drug Delivery Systems: Continuous-Release Systems
Drug Dosing: Geriatric Patients
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant